Generic Price Regulation and Drug Expenditures: Evidence From Canada

Keyphrases

• Canada 100%
• Drug Expenditure 100%
• Price Regulation 100%
• Pricing Policy 50%
• Rapid Growth 25%
• Demand Side 25%
• Out-of-pocket Expenditure 25%
• Policy Impact 25%
• Claims Data 25%
• Pharmaceutical Expenditure 25%
• Cost Sharing 25%
• Triple Difference 25%
• Canadian Government 25%
• Cost Containment 25%
• Prescription Claims 25%
• Inelastic Demand 25%
• Difference-in-differences Methodology 25%
• Policy Variation 25%
• Generic Drugs 25%
• Demand-side Regulation 25%
• Reduced Price 25%
• Drug Utilization 25%
• Total Demand 25%
• Demand Incentive 25%
• Co-payment 25%
• Coinsurance 25%
• Difference Approach 25%
• Health Insurance Design 25%

Economics, Econometrics and Finance

• Incentives 100%
• Pricing Policy 100%
• Price Regulation 100%
• Difference-In-Differences 50%
• Deductible 50%
• Health Insurance 50%